Molecular imaging: current status and emerging strategies
MA Pysz, SS Gambhir, JK Willmann - Clinical radiology, 2010 - Elsevier
In vivo molecular imaging has a great potential to impact medicine by detecting diseases in
early stages (screening), identifying extent of disease, selecting disease-and patient-specific …
early stages (screening), identifying extent of disease, selecting disease-and patient-specific …
PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques
Historically, anatomical CT and MR images were used to delineate the gross tumour
volumes (GTVs) for radiotherapy treatment planning. The capabilities offered by modern …
volumes (GTVs) for radiotherapy treatment planning. The capabilities offered by modern …
Assessing tumor response to therapy
WA Weber - Journal of nuclear medicine, 2009 - Soc Nuclear Med
Most anticancer drugs are effective only in subgroups of patients, and our current
understanding of tumor biology does not allow us to predict accurately which patient will …
understanding of tumor biology does not allow us to predict accurately which patient will …
Radiopharmaceutical chemistry for positron emission tomography
Z Li, PS Conti - Advanced drug delivery reviews, 2010 - Elsevier
Molecular imaging is an emerging technology that allows the visualization of interactions
between molecular probes and biological targets. Molecules that either direct or are subject …
between molecular probes and biological targets. Molecules that either direct or are subject …
In vivo imaging in cancer
J Condeelis, R Weissleder - Cold Spring Harbor …, 2010 - cshperspectives.cshlp.org
Imaging has become an indispensable tool in the study of cancer biology and in clinical
prognosis and treatment. The rapid advances in high resolution fluorescent imaging at …
prognosis and treatment. The rapid advances in high resolution fluorescent imaging at …
A practical guide to the construction of radiometallated bioconjugates for positron emission tomography
Positron emission tomography (PET) has become a vital imaging modality in the diagnosis
and treatment of disease, most notably cancer. A wide array of small molecule PET …
and treatment of disease, most notably cancer. A wide array of small molecule PET …
Unconventional nuclides for radiopharmaceuticals
JP Holland, MJ Williamson, JS Lewis - Molecular imaging, 2010 - journals.sagepub.com
Rapid and widespread growth in the use of nuclear medicine for both diagnosis and therapy
of disease has been the driving force behind burgeoning research interests in the design of …
of disease has been the driving force behind burgeoning research interests in the design of …
A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?
S Vallabhajosula, L Solnes, B Vallabhajosula - Seminars in nuclear …, 2011 - Elsevier
Positron emission tomography (PET)/computed tomography (CT) is a rapidly expanding
imaging modality, thanks to the availability of compact medical cyclotrons and automated …
imaging modality, thanks to the availability of compact medical cyclotrons and automated …
[HTML][HTML] Approaches to PET imaging of glioblastoma
LR Drake, AT Hillmer, Z Cai - Molecules, 2020 - mdpi.com
Glioblastoma multiforme (GBM) is the deadliest type of brain tumor, affecting approximately
three in 100,000 adults annually. Positron emission tomography (PET) imaging provides an …
three in 100,000 adults annually. Positron emission tomography (PET) imaging provides an …
[HTML][HTML] Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer
J Cuaron, M Dunphy, A Rimner - Frontiers in oncology, 2013 - frontiersin.org
The integral role of positron-emission tomography (PET) using the glucose analog tracer
fluorine-18 fluorodeoxyglucose (FDG) in the staging of non-small cell lung cancer (NSCLC) …
fluorine-18 fluorodeoxyglucose (FDG) in the staging of non-small cell lung cancer (NSCLC) …